BLACK WEEK DEAL 50% off all yearly plans. 🔥 See what we offer →

Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

ema.europa.eu

What's new

Get the latest updates from What's new directly as they happen.

Follow now 302 followers

Latest posts

Last updated 2 minutes ago

Human medicines European public assessment report (EPAR): Siklos, hydroxycarbamide, Date of authorisation: 29/06/2007, Revision: 28, Status: Authorised

6 minutes ago

Human medicines European public assessment report (EPAR): Siklos, hydroxycarbamide, Date of authorisation...

Human medicines European public assessment report (EPAR): Crysvita, burosumab, Date of authorisation: 19/02/2018, Revision: 16, Status: Authorised

about 2 hours ago

Human medicines European public assessment report (EPAR): Crysvita, burosumab, Date of authorisation...

Human medicines European public assessment report (EPAR): Pradaxa, dabigatran etexilate, Date of authorisation: 17/03/2008, Revision: 44, Status: Authorised

about 2 hours ago

Human medicines European public assessment report (EPAR): Pradaxa, dabigatran etexilate, Date of...

Human medicines European public assessment report (EPAR): Hizentra, human normal immunoglobulin (SCIg), Date of authorisation: 14/04/2011, Revision: 28, Status: Authorised

about 4 hours ago

Human medicines European public assessment report (EPAR): Hizentra, human normal immunoglobulin (SCIg)...

PSUSA/00002510/202501

about 4 hours ago

PSUSA/00002510/202501

Human medicines European public assessment report (EPAR): Xermelo, telotristat ethyl, Date of authorisation: 17/09/2017, Revision: 17, Status: Authorised

about 5 hours ago

Human medicines European public assessment report (EPAR): Xermelo, telotristat ethyl, Date of...

Human medicines European public assessment report (EPAR): Denbrayce, denosumab, Date of authorisation: 26/06/2025, Revision: 1, Status: Authorised

about 5 hours ago

Human medicines European public assessment report (EPAR): Denbrayce, denosumab, Date of authorisation...

Human medicines European public assessment report (EPAR): Ebvallo, tabelecleucel, Date of authorisation: 16/12/2022, Revision: 7, Status: Authorised

about 5 hours ago

Human medicines European public assessment report (EPAR): Ebvallo, tabelecleucel, Date of authorisation...

Human medicines European public assessment report (EPAR): Mayzent, siponimod, Date of authorisation: 13/01/2020, Revision: 19, Status: Authorised

about 6 hours ago

Human medicines European public assessment report (EPAR): Mayzent, siponimod, Date of authorisation...

PRAC recommendations on safety signals

about 6 hours ago

PRAC recommendations on safety signals

List of signals discussed at PRAC since September 2012

about 7 hours ago

List of signals discussed at PRAC since September 2012

PRAC recommendations on signals adopted at the 27-30 October 2025 PRAC meeting

about 7 hours ago

PRAC recommendations on signals adopted at the 27-30 October 2025 PRAC meeting